BPC-157

Body Protection Compound-157 — a pentadecapeptide for systemic and localized tissue healing of the gastrointestinal tract, ligaments, tendons, and muscles.

We supply BPC-157 at ≥99% (HPLC) purity. Higher purity grades are available for pharmaceutical applications upon request.

Minimum order quantities for wholesale BPC-157 depend on the quantity and purity grade required. Contact our sales team for specific pricing and MOQ information.

BPC-157 should be stored at -20°C, desiccated in a desiccated environment. Proper cold-chain shipping is maintained for all deliveries.

After reconstitution with bacteriostatic water, BPC-157 solution should be stored at 2–8°C (refrigerated) and used within 30 days. According to ICH Q5C stability guidelines for biotechnological products, reconstituted peptides are susceptible to degradation from hydrolysis and oxidation. For long-term storage, maintain lyophilized form at -20°C under inert atmosphere.

Each lot of BPC-157 from Dr. Peptides includes a comprehensive Certificate of Analysis containing: HPLC purity analysis (≥99%), mass spectrometry confirmation (MW: 1419.53 ± 0.1 Da), amino acid analysis (15 residues verified), residual solvent analysis per ICH Q3C, endotoxin testing (<0.5 EU/mg), and moisture content (<2% by Karl Fischer titration).

According to a 2023 publication in the Journal of Pharmaceutical Sciences, peptide impurities above 1% can introduce dose-response variability of up to 15% in biological assays. Dr. Peptides supplies BPC-157 at ≥99% purity to ensure reproducible experimental results. All impurity profiles are characterized and documented on the Certificate of Analysis.

Dr. Peptides offers BPC-157 in lyophilized powder form in quantities from 10mg to 10g+ per vial. Available as free base or acetate salt form. Custom packaging and labeling available for OEM clients. All formats shipped under argon atmosphere in pharmaceutical-grade amber glass vials with tamper-evident seals.

Yes, Dr. Peptides can supply BPC-157 manufactured under full GMP conditions suitable for IND-enabling studies and clinical trials. We provide Drug Master File (DMF) documentation, process validation records, and stability data packages as required by FDA 21 CFR Parts 210/211 and ICH Q7 guidelines. Contact our regulatory affairs team for clinical-grade quotations.